FDA PDUFA dates, insider filings, and clinical trial data across 970 biotech companies — scored, ranked, and updated daily.
BiotechSign tracks FDA PDUFA dates, insider buying, clinical trial activity, dilution risk, short interest, congressional trades, and convergence signals across 970 biotech companies. The platform publishes free daily Intel articles at biotechsign.com/intel covering PDUFA previews, pipeline deep dives, insider surges, and grade changes — no account required. Currently showing 203,762 active catalyst signals, with top-ranked tickers including AQUA, BIS, BIOS, ADIL, ANTE.
BiotechSign monitors FDA decision deadlines and surfaces upcoming PDUFA dates with company, drug, indication, and timing context.
Clinical trial signals summarize active studies, trial phase, recruitment activity, and company-level catalyst density from ClinicalTrials.gov data.
Insider buying signals track SEC Form 4 activity and highlight clusters where executives or directors recently purchased shares.
Catalyst previews, pipeline deep dives, insider surge reports, and grade changes written daily from live BiotechSign data. Always free.
This page was refreshed on 2026-07-02. Data comes from FDA, SEC EDGAR, ClinicalTrials.gov, DilutionWatch, StonkWhisper, and internal signal scoring jobs.
Filtered by signal type — updated daily by our sentinel network
Not financial advice — these are common research workflows that investors apply when using catalyst intelligence platforms.
Investor wants to identify biotech companies with FDA approval decisions in the next 30 days.
Multiple insiders at the same company bought shares in the last 30 days — often a leading indicator.
Trader wants to identify biotech stocks at high risk of a dilutive offering before it happens.
Research analyst tracking upcoming Phase 2→3 transitions and primary completion dates.
Swing trader looking for biotech names where technical momentum and fundamental catalysts align.
Investor tracking when sitting members of Congress buy biotech stocks ahead of FDA decisions.
Three always-on sentinels scrape SEC EDGAR, ClinicalTrials.gov, and FDA databases daily across every tracked biotech company.
When a catalyst is detected — PDUFA deadline, insider Form 4, trial phase update — a scored signal is generated with context and timeline.
Browse the screener, set watchlist alerts, and dig into company deep-dives with full signal history and DW/SW data overlays.
Start free. Unlock everything when you need the edge.